Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...Soriot is already among the highest-paid bosses in the FTSE with a £16.9mn deal in 2023 and takes home more than the chiefs of European pharmaceutical rivals....
...Western pharmaceutical companies are in talks with alternative suppliers in response to draft US legislation seeking to restrict an important Chinese drug developer and manufacturer over national security...
...Soriot already earns more than bosses of larger European pharmaceutical companies....
...The company is also a partner for several pharmaceutical companies....
...Still, Delaware, Inc is going to have to decide whether its brand should be based on being an even-handed, dispassionate system or something more corporate-friendly, designed to keep up in a regulatory race...
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...This has led to western pharmaceutical regulators struggling to enforce oversight of Chinese manufacturers....
...Emblaveo, marketed in Europe by US pharmaceutical company Pfizer, combines two existing medicines to tackle so-called Gram-negative bacteria that are among the leading drug-resistance threats....
...It is a similar milestone-based structure to many partnerships in the pharmaceutical industry....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...That holds true for pharmaceutical companies which are looking a bit peaky. Roche, whose stock has fallen 27 per cent in the past 12 months, is a case in point....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...It needs further deals to replenish its pharmaceuticals pipeline....
...Neither McNeil nor Carson could put a figure on the number of ETFs that might have bypassed UK, depriving the London stock exchange of their listing and UK investors of the opportunity to access them....
...The former Roche pharmaceuticals boss took on one of the most unenviable jobs in corporate Europe last June....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
...In February, the UK pharmaceuticals company hit a long-term sales target that once seemed out of reach....
...Ireland’s economy has officially entered recession after contracting by 1.9 per cent in the third quarter, pushed lower by a drop in pharmaceutical exports....
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
...WuXi AppTec is a major supplier of essential ingredients to many of the largest global pharmaceutical companies and conducts drug development for them....
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
...An Indian pharmaceutical manufacturer, Intas, is a major supplier of finished dosage methotrexate to the US through its subsidiary Accord Healthcare....
...referred to in the essay albeit not by name, Samuel P Huntington wrote that “if civilisation is what counts . . . violence between Ukrainians and Russians is unlikely”, being two Slavic, primarily Orthodox...
International Edition